Back

Pharmacological class interventions for benzodiazepine withdrawal discontinuation: a meta-analysis

2020-07-10 pharmacology and therapeutics Title + abstract only
View on medRxiv
Show abstract

BackgroundLong-term benzodiazepine (BZD) use may lead to dependence, addiction, and neuropsychiatric disturbances. BZD discontinuation can cause severe withdrawal symptoms and resurgence of premorbid conditions. There are guidelines on how to stop BZD if it is necessary. Pharmacological management is an option among several other recommendations, but its benefit remains unclear. This study investigates whether certain pharmacological classes can manage or facilitate BZD withdrawal beyond BZD it...

Predicted journal destinations